CSL:ASX
CSL Ltd
A$202.92
arrow_downward
-0.79%(-1.62) 1D
Nov 13, 4:10:12 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$203.49
High
A$205.48
Low
A$201.14
Mkt. cap
97.38B
Avg. vol.
988.76K
Volume
878.56K
Dividend
1.40%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$205.48
52-wk low
A$90.00
EPS
-A$7.79
Shares outstanding
479.88M
No. of employees
29K
Open
A$203.49
High
A$205.48
Low
A$201.14
Mkt. cap
97.38B
Avg. vol.
988.76K
Volume
878.56K
Dividend
1.40%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$205.48
52-wk low
A$90.00
EPS
-A$7.79
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
Medical Republic
·
18 hours ago
Q fever vaccine stocks set to run dry
Kalkine
·
23 hours ago
CSL Limited Buys Back 35,318 Shares on 12 November 2026 in On-Market Program
TheBull.com.au
·
1 day ago
CSL Shares At 52Wk Highs: Can The Rally Stretch To Sixth Months?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorHealth Care
IndustryBiotechnology
Websitecsl.com